Alexander G. Balogh

Alberta Cancer Foundation — Canada

Medicine · Health Sciences

12h-index1.6kcitations25works1.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(18), Prostate Cancer Treatment and Research(18), Advanced Radiotherapy Techniques(7), Radiomics and Machine Learning in Medical Imaging(5), Bladder and Urothelial Cancer Treatments(3)

Publications25 total

Long-Term Results of NRG/RTOG 9601, a Randomized Trial of Radiation With or Without Antiandrogens in Patients Receiving Salvage Prostate Bed Radiation Therapy Postprostatectomy
International Journal of Radiation Oncology*Biology*Physics·2025· 5 citedOpen Access
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy
The Prostate·2025Open Access
The prognostic impact of prostate-specific antigen at 6 months after post-prostatectomy radiotherapy: An individual patient data analysis of two NRG oncology randomized trials.
Journal of Clinical Oncology·2025
Evaluation of post radiotherapy PSA as a prognostic and predictive biomarker in high risk prostate cancer: A secondary analysis of RTOG 0521.
Journal of Clinical Oncology·2025
Corrigendum to “Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostat Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial” [Eur. Eurol. 84(2) (2023) 156–163]
European Urology·2024
1359: Individual patient data analysis of salvage radiotherapy trials: RTOG 0534 and GETUG-AFU 16
Radiotherapy and Oncology·2024
PD42-11 DEVELOPMENT AND VALIDATION OF A MULTIMODAL ARTIFICIAL INTELLIGENCE (MMAI)-DERIVED DIGITAL PATHOLOGY-BASED BIOMARKER PREDICTING METASTASIS FOR RADICAL PROSTATECTOMY PATIENTS WITH BIOCHEMICAL RECURRENCE IN NRG/RTOG TRIALS
The Journal of Urology·2024· 3 cited
Long-term results of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy (sRT) post prostatectomy.
Journal of Clinical Oncology·2024
Neurocognitive function outcomes in NRG/RTOG 0534, the SPPORT trial.
Journal of Clinical Oncology·2023
Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial
European Urology·2023· 19 citedOpen Access
Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials
npj Digital Medicine·2023· 4 citedOpen Access
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601
Journal of Clinical Oncology·2022· 24 citedOpen Access
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials
npj Digital Medicine·2022· 166 citedOpen Access
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial
The Lancet·2022· 233 citedOpen Access
Impact of lymph node yield at prostatectomy on outcomes in NRG/RTOG 9601.
Journal of Clinical Oncology·2022
Adjuvant docetaxel for high-risk localized prostate cancer: Update of NRG Oncology/RTOG 0521.
Journal of Clinical Oncology·2020· 11 cited
MP72-01 IMPROVEMENTS IN FREEDOM FROM PROGRESSION WITH SHORT TERM ANDROGEN DEPRIVATION THERAPY AND PELVIC LYMPH NODE TREATMENT ADDED TO PROSTATE BED SALVAGE RADIOTHERAPY: THE NRG ONCOLOGY/RTOG 0534 SPPORT TRIAL
The Journal of Urology·2019· 2 citedOpen Access
Effect of Chemotherapy With Docetaxel With Androgen Suppression and Radiotherapy for Localized High-Risk Prostate Cancer: The Randomized Phase III NRG Oncology RTOG 0521 Trial
Journal of Clinical Oncology·2019· 146 citedOpen Access
Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
Advances in Radiation Oncology·2017· 18 citedOpen Access
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
New England Journal of Medicine·2017· 650 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Howard M. Sandler(23), Jeff M. Michalski(14), Luís Souhami(13), Seth A. Rosenthal(13), William U. Shipley(12), Felix Y. Feng(11), Thomas M. Pisansky(10), Leonard G. Gomella(10), George Rodrigues(10), Oliver Sartor(9), Stephanie L. Pugh(9), Himanshu Lukka(8), Kenneth L. Zeitzer(8), Jean-Paul Bahary(8), Jason A. Efstathiou(8), Wendy Seiferheld(7), Mahul B. Amin(7), Scott Williams(7), Theodore Karrison(6), Adam Raben(6)